Gasdermin E dictates inflammatory responses by controlling the mode of neutrophil death

Fengxia Ma,Laxman Ghimire,Qian Ren,Yuping Fan,Tong Chen,Arumugam Balasubramanian,Alan Hsu,Fei Liu,Hongbo Yu,Xuemei Xie,Rong Xu,Hongbo R. Luo

DOI: https://doi.org/10.1038/s41467-023-44669-y

IF: 16.6

2024-01-09

Nature Communications

Abstract:Abstract Both lytic and apoptotic cell death remove senescent and damaged cells in living organisms. However, they elicit contrasting pro- and anti-inflammatory responses, respectively. The precise cellular mechanism that governs the choice between these two modes of death remains incompletely understood. Here we identify Gasdermin E (GSDME) as a master switch for neutrophil lytic pyroptotic death. The tightly regulated GSDME cleavage and activation in aging neutrophils are mediated by proteinase-3 and caspase-3, leading to pyroptosis. GSDME deficiency does not alter neutrophil overall survival rate; instead, it specifically precludes pyroptosis and skews neutrophil death towards apoptosis, thereby attenuating inflammatory responses due to augmented efferocytosis of apoptotic neutrophils by macrophages. In a clinically relevant acid-aspiration-induced lung injury model, neutrophil-specific deletion of GSDME reduces pulmonary inflammation, facilitates inflammation resolution, and alleviates lung injury. Thus, by controlling the mode of neutrophil death, GSDME dictates host inflammatory outcomes, providing a potential therapeutic target for infectious and inflammatory diseases.

multidisciplinary sciences

What problem does this paper attempt to address?

This paper aims to explore the role of Gasdermin E (GSDME) in the regulation of neutrophil death patterns and its impact on the host inflammatory response. Specifically, the researchers identified GSDME as the main switch that determines the lytic pyroptosis death of neutrophils. Through the tightly regulated cleavage and activation by Proteinase - 3 (PR3) and Caspase - 3 (caspase - 3), pyroptosis is triggered in senescent neutrophils. GSDME deficiency does not change the overall survival rate of neutrophils; instead, it specifically prevents pyroptosis and biases the death of neutrophils towards apoptosis, thereby enhancing the phagocytosis of apoptotic neutrophils by macrophages and attenuating the inflammatory response.

The study also found that in a clinically relevant acid - inhalation - induced lung injury model, neutrophil - specific deletion of GSDME can reduce lung inflammation, promote inflammation resolution, and alleviate lung injury. Therefore, by controlling the way neutrophils die, GSDME determines the inflammatory outcome of the host, providing a potential therapeutic target for infectious and inflammatory diseases.